688089.SS
Price:
$28.01
Market Cap:
$4.70B
Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. Its products are used in infant formula food, health food, dietary supplements, and other fields for special medical purposes, pet nutrition food, economic animal feed, personal care and cosmetics, and other fields. The company was founded in 1999 and is based in Wuhan, the People's Republic of China.
Industry
Biotechnology
IPO Date
2019-12-19
Stock Exchange
SHH
Ticker
688089.SS
According to Cabio Biotech (Wuhan) Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 32.20. This represents a change of 17.92% compared to the average of 27.31 of the last 4 quarters.
The mean historical PE Ratio of Cabio Biotech (Wuhan) Co., Ltd. over the last ten years is 67.96. The current 32.20 PE Ratio has changed 4.64% with respect to the historical average. Over the past ten years (40 quarters), 688089.SS's PE Ratio was at its highest in in the March 2023 quarter at 82.02. The PE Ratio was at its lowest in in the December 2022 quarter at -99.11.
Average
67.96
Median
50.05
Minimum
25.72
Maximum
209.87
Discovering the peaks and valleys of Cabio Biotech (Wuhan) Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 169.75%
Maximum Annual PE Ratio = 209.87
Minimum Annual Increase = -60.76%
Minimum Annual PE Ratio = 25.72
Year | PE Ratio | Change |
---|---|---|
2024 | 25.72 | -22.42% |
2023 | 33.15 | -60.76% |
2022 | 84.48 | 47.32% |
2021 | 57.35 | 57.56% |
2020 | 36.40 | -3.72% |
2019 | 37.80 | -11.58% |
2018 | 42.75 | -32.41% |
2017 | 63.25 | -28.77% |
2016 | 88.79 | -57.69% |
2015 | 209.87 | 169.75% |
The current PE Ratio of Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
47.78
5-year avg
47.42
10-year avg
67.96
Cabio Biotech (Wuhan) Co., Ltd.’s PE Ratio is less than Giantec Semiconductor Corporation (0), less than Traffic Control Technology Co., Ltd. (0), less than Suntar Environmental Technology Co., Ltd. (35.84), less than null (45.09), greater than null (13.32),
Company | PE Ratio | Market cap |
---|---|---|
0 | $12.15B | |
0 | $3.84B | |
35.84 | $4.33B | |
45.09 | $0 | |
13.32 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cabio Biotech (Wuhan) Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cabio Biotech (Wuhan) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cabio Biotech (Wuhan) Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Cabio Biotech (Wuhan) Co., Ltd. (688089.SS)?
What is the highest PE Ratio for Cabio Biotech (Wuhan) Co., Ltd. (688089.SS)?
What is the 3-year average PE Ratio for Cabio Biotech (Wuhan) Co., Ltd. (688089.SS)?
What is the 5-year average PE Ratio for Cabio Biotech (Wuhan) Co., Ltd. (688089.SS)?
How does the current PE Ratio for Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) compare to its historical average?